More Good News for Empagliflozin in Patients with Heart Failure

Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial

Related Keywords

New York ,United States ,France ,American ,Dapagliflozin Farxiga ,Faiez Zannad ,Empagliflozin Jardiance ,American Society Of Nephrology ,European Society Of Cardiology ,Hf New York Heart Association ,American Society ,New York Heart Association ,New York City ,